Literature DB >> 27914308

Regulation of T helper cell differentiation by E3 ubiquitin ligases and deubiquitinating enzymes.

Si-Fa Gao1, Bo Zhong2, Dandan Lin3.   

Abstract

CD4 T cells are essential components of adaptive immunity and play a critical role in anti-pathogenic or anti-tumor responses as well as autoimmune and allergic diseases. Naive CD4 T cells differentiate into distinct subsets of T helper (Th) cells by various signals including TCR, costimulatory and cytokine signals. Accumulating evidence suggests that these signaling pathways are critically regulated by ubiquitination and deubiquitination, two reversible posttranslational modifications mediated by E3 ubiquitin ligases and deubiquitinating enzymes (DUBs), respectively. In this review, we briefly introduce the signaling pathways that control the differentiation of Th cells and then focused on the roles of E3s- and DUBs-mediated ubiquitin modification or demodification in regulating Th cell differentiation.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Deubiquitinating enzymes; E3 ubiquitin ligases; T helper cell differentiation

Mesh:

Substances:

Year:  2016        PMID: 27914308     DOI: 10.1016/j.intimp.2016.11.013

Source DB:  PubMed          Journal:  Int Immunopharmacol        ISSN: 1567-5769            Impact factor:   4.932


  3 in total

1.  [Cbl-b gene silencing enhances H9 T lymphocyte-mediated killing of human laryngeal squamous cancer Hep-2 cells].

Authors:  Saiming Chen; Zhiqun Li; Limin Zhou; Yunxia Zhang
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2019-05-30

2.  E3 ubiquitin ligases STUB1/CHIP contributes to the Th17/Treg imbalance via the ubiquitination of aryl hydrocarbon receptor in rheumatoid arthritis.

Authors:  Wen Wang; Ting Xiang; Yachen Yang; Zitao Wang; Jianmin Xie
Journal:  Clin Exp Immunol       Date:  2022-09-29       Impact factor: 5.732

3.  USP38 critically promotes asthmatic pathogenesis by stabilizing JunB protein.

Authors:  Siyuan Chen; Fenglin Yun; Yikun Yao; Mengtao Cao; Yifan Zhang; Jingjing Wang; Xinyang Song; Youcun Qian
Journal:  J Exp Med       Date:  2018-09-17       Impact factor: 14.307

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.